Centers for Disease Control and Prevention (CDC), Procurement & Grants Office, 255 East Paces Ferry Road, N.E., Room No. 419 Atlanta, Georgia 30305

65 -- ENHANCED POLIOVIRUS VACCINE (E-IPV) POC Contact Donna Cooper at (404)842-6764 The Centers for Disease Control and Prevention (CDC) intends to negotiate with Connaught Laboratories, Inc. on a sole source basis for the modification of existing Indefinite quantity contract to increase the Maximum Estimated Quantity of Item B.1, Enhanced Inactivated Poliovirus Vaccine (E-IPV) by an additional 175,000 doses. Authority - 41 U.S.C. 253 (c)(1), only one available source. Interested parties that believe they can meet this requirement should respond directly to this office. This procurement action shall be conducted in accordance with Section 13631 of the Omnibus Budget Reconciliation Act of 1993. FDA product license required. See Note 22. (0340)

Loren Data Corp. http://www.ld.com (SYN# 0290 19951207\65-0003.SOL)